Real-life Data from Diabetic Patients on Closed-loop Pumps
NCT ID: NCT05418699
Last Updated: 2025-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
439 participants
OBSERVATIONAL
2022-09-26
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
NCT05348499
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
NCT00831389
Comparison With Observational Methods and Performance Assessment From Real-life Experience of Closed-Loop Insulin Delivery Systems
NCT05932966
Initial Testing of the Diabeloop Algorithm in T1D Patients on Pump Therapy Over the Prandial Period and Physical Activity.
NCT01754181
Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life
NCT04939766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type I diabetic patient
closed-loop insulin pump
Follow up of patients with real-time closed-loop insulin delivery systems
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
closed-loop insulin pump
Follow up of patients with real-time closed-loop insulin delivery systems
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a closed-loop insulin pump
Exclusion Criteria
* patient or legal guardian objecting to the use of the data in the research
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier de la Rochelle Ré Aunis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Didier GOUET, MD
Role: STUDY_DIRECTOR
Groupe Hospitalier de la Rochelle Ré Aunis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Béthune-Beuvry
Béthune, , France
CH Boulogne-sur-Mer
Boulogne-sur-Mer, , France
CH Dax
Dax, , France
CHI Mont de Marsan et du Pays des Sources
Mont-de-Marsan, , France
CH Périgueux
Périgueux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/P02/540
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.